欢迎来到西安迈博睿(Mabioway)生物科技有限公司 Call: 15339069646 | E-mail: info@mabioway.cn 在线留言 |

服务热线

15339069646
网站导航
当前位置: 首页 > 产品展示 > 抗体产品 > 一抗 > 其他抗体
其他抗体

Anti-BCMA mAbs

简要描述:

This antibody binds human BCMA. It acts as a receptor for TNFSF13B/BLyS/BAFF and TNFSF13/APRIL. BCMA expression is highest on terminally differentiated B cells. BCMA is involved in mediating the survival of plasma cells for maintaining long-term humoral immunity. It also activates NF- kappa-B and JNK. The expression of BCMA has been linked to a number of cancers, autoimmune disorders, and infectious diseases.

产品参数:

Cat. No.:MABL-494

Species:Engineer

Species Reactivity:Human

Type:Recombinate

Application:ELISA, FC

详细介绍

Key features and details

Cat. No.

MABL-494

Name

Anti-BCMA mAbs

Clone No.

AFD- 13A4

From

Recombinant Antibody

Isotype

Engineer antibody

Application

ELISA, FC

Species Reactivity

Human

Basic Information

Specificity

This antibody binds human BCMA. It acts as a   receptor for TNFSF13B/BLyS/BAFF and TNFSF13/APRIL. BCMA expression is highest   on terminally differentiated B cells. BCMA is involved in mediating the   survival of plasma cells for maintaining long-term humoral immunity. It also   activates NF- kappa-B and JNK. The expression of BCMA has been linked to a   number of cancers, autoimmune disorders, and infectious diseases.

Alternative Name

CD269; BCM; TNFRSF17; Tumor necrosis factor   receptor superfamily member 17; B-cell maturation protein

UniProt

Q02223

Immunogen

The original antibody was isolated from a   generic Fab antibody library by panning against biotinylated ectodomain of   BCMA.

Application Notes

The selection of specific binders having   affinity for BCMA was done using ELISA and their affinity was determined   using SPR analysis. The original Fab antibody bound human BCMA with a   monovalent binding affinity of 1.8 nM. The binding of the IgG version of this   antibody to membrane bound human BCMA was determined by performing flow   cytometry on BCMA-expressing H929 cells and MKN45 cells. The assessment of   the competition between A-APRIL and this antibody was performed on H929 cells   by quantifying the binding of A-APRIL in presence of increasing   concentrations of this antibody and measured by flow cytometry. This antibody   was reported to not block or increase APRIL-dependent NF-κB activation and   also does not block or increase BAFF-dependent NF-κB activation in vitro.   This antibody was also reported to be used in the generation of antibody-drug   conjugates and anti-BCMA/anti-CD3 T cell bispecific antibodies for possible   immunotherapy applications in treatment of multiple myelomas (EP2953972).

Antibody First Published


Note on publication


COA Information For reference only, actual COA shall prevail

Size

100 μg Purified antibody.

Concentration

1 mg/ml.

Purification

Protein A affinity purified

Buffer

PBS with 0.02% Proclin 300.

Concentration

1 mg/ml.

Storage Recommendation

Store at 4⁰C for up to 3 months. For   longer storage, aliquot and store at - 20⁰C.


 


服务咨询

留言框

  • 标题:

  • 留言内容:

  • 您的单位:

  • 您的姓名:

  • 联系电话:

  • 常用邮箱:

  • 详细地址:

上一篇: Anti-Bcl-3 mAbs

下一篇: Anti-BCMA mAbs

推荐产品

联系我们

Copyright © 2012-2029 西安迈博睿(Mabioway)生物科技有限公司 版权所有

地址:陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层

电话:15339069646 邮箱:info@mabioway.cn

陕ICP备2021006339号